This topic contains a solution. Click here to go to the answer

Author Question: The innermost layer of the skin is called the A) dermis. B) epidermis. C) hypodermis ... (Read 43 times)

Yolanda

  • Hero Member
  • *****
  • Posts: 757
The innermost layer of the skin is called the
 
  A) dermis.
   B) epidermis.
   C) hypodermis (subcutaneous fascia).
   D) necrotizing fascia.

Question 2

_______________________ occurs when radioactive materials get onto the body or clothing of the victim.
 
  a. Irradiation
  b. Contamination
  c. Ingestion
  d. Exposure



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

yahahah24021

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

C

Answer to Question 2

b
Rationale: a. Irradiation occurs when the energy from radiation damages a person's cell.
b. Correct.
c. Ingestion in the intake (orally) of contaminated materials.
d. Exposure is being in an area where radioactive materials may be present.




Yolanda

  • Member
  • Posts: 757
Reply 2 on: Jul 3, 2018
Wow, this really help


T4T

  • Member
  • Posts: 348
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

If you could remove all of your skin, it would weigh up to 5 pounds.

Did you know?

Once thought to have neurofibromatosis, Joseph Merrick (also known as "the elephant man") is now, in retrospect, thought by clinical experts to have had Proteus syndrome. This endocrine disease causes continued and abnormal growth of the bones, muscles, skin, and so on and can become completely debilitating with severe deformities occurring anywhere on the body.

Did you know?

The first oncogene was discovered in 1970 and was termed SRC (pronounced "SARK").

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library